Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published [...]